REFERENCES
- Gisbert JP, González-Lama Y, Maté J. 5-Aminosalicylates and renal function in inflammatory bowel disease: A systematic review. Inflamm Bowel Dis. 2007; 13: 629–638
- Uslu N, Demir H, Saltik-Temizel IN, et al. Acute tubular injury associated with mesalazine therapy in an adolescent girl with inflammatory bowel disease. Dig Dis Sci. 2007; 52: 2926–2929
- Arend LJ, Springate JE. Interstitial nephritis from mesalazine: Case report and literature review. Pediatr Nephrol. 2004; 19: 550–553
- Elseviers MM, D'Haens G, Lerebours E, et al. Renal impairment in patients with inflammatory bowel disease: Association with aminosalicylate therapy?. Clin Nephrol. 2004; 61: 83–89
- World MJ, Stevens PE, Ashton MA, et al. Mesalazine-associated interstitial nephritis. Nephrol Dial Transplant. 1996; 11: 614–621
- Corrigan G, Stevens PE. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Aliment Pharmacol Ther. 2000; 14: 1–6
- Benador N, Grimm P, Lemire J, et al. Interstitial nephritis in children with Crohn's disease. Clin Pediatr. 2000; 39: 253–254
- Van Biervliet S, Raes A, Vande Walle J, et al. Mesalazine interstitial nephritis presenting as colitis ulcerosa exacerbation. Acta Gastroenterol Belg. 2006; 69: 321–322
- Tadic M, Grgurevic I, Scukanec-Spoljar M, et al. Acute interstitial nephritis due to mesalazine. Nephrology. 2005; 10: 103–105
- Ohya M, Otani H, Kimura K, et al. Interstitial nephritis induced by mesalazine. Nippon Jinzo Gakkai Shi. 2002; 44: 414–419